Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient
- Conditions
- Interventions
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 105
- Registration Number
- NCT01871961
- Locations
- 🇺🇸
Rheumatology Arthitis & Rheumatic Care center, South Miami, Florida, United States
Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)
- Conditions
- Interventions
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2013-07-15
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 120
- Registration Number
- NCT01793259
- Locations
- 🇩🇪
Kerckhoff Clinic, Bad Nauheim, Germany
Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia
- Conditions
- Interventions
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 56
- Registration Number
- NCT01251809
- Locations
- 🇩🇪
Charité Campus Benjamin Franklin Hämatologie, Onkologie, Transfusionsmedizin Medizinische Klinik III, Berlin, Germany
🇩🇪Universitätsklinikum Heidelberg, Heidelberg, Germany
🇩🇪Universitätsklinikum Frankfurt Medizinische Klinik II, Frankfurt, Germany
Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2010-02-05
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 75
- Registration Number
- NCT01063660
- Locations
- 🇩🇪
University of Rostock, Rostock, Germany
Dose-range Finding Treosulfan-based Conditioning
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 56
- Registration Number
- NCT01063647
- Locations
- 🇵🇱
Silesian Medical University, Katowice, Poland
🇫🇮Helsinki University Central Hospital, Helsinki, Finland
🇩🇪Charité University Hospital Berlin, Berlin, Germany
Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT01062490
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2011-03-01
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT00983138
- Locations
- 🇩🇪
University Hospital Erlangen, Erlangen, Germany
🇳🇱Sophia Children's Hospital, Rotterdam, Netherlands
🇩🇪University Hospital Bonn, Bonn, Germany
Urokinase Therapy in Patients With Diabetic Foot Syndrome
- Conditions
- Interventions
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2015-03-13
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 5
- Registration Number
- NCT00823225
- Locations
- 🇩🇪
Franziskus Krankenhaus, Berlin, Germany
🇩🇪Klinikum Dortmund Nord GmbH, Dortmund, Germany
🇩🇪Klinikum Karlsbad Langensteinbach, Karlsbad, Germany
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
- Conditions
- Interventions
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 570
- Registration Number
- NCT00822393
- Locations
- 🇮🇹
Ospedale Civile Pescara, Pescara, Italy
🇩🇪Universitätsklinikum Freiburg, Freiburg, Germany
🇩🇪Klinikum Nürnberg, 5. Medizinische Klinik, Nürnberg, Germany
Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia
- Conditions
- Interventions
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2013-02-27
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 199
- Registration Number
- NCT00784017
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands